Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Muscarinic acetylcholine receptor M3 | ||
Ligand | BDBM50296329 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | [3H]-NMS Binding Assay | ||
IC50 | 2.7±n/a nM | ||
Citation | Fernandez Forner, MD; Prat Quinones, M; Buil Albero, MA Quinuclidine derivatives and medicinal compositions containing the same US Patent US9333195 Publication Date 5/10/2016 | ||
More Info.: | Get all data from this article, Assay Method | ||
Muscarinic acetylcholine receptor M3 | |||
Name: | Muscarinic acetylcholine receptor M3 | ||
Synonyms: | ACM3_HUMAN | CHRM3 | Cholinergic, muscarinic M3 | Muscarinic Receptors M3 | Muscarinic receptor M3 | RecName: Full=Muscarinic acetylcholine receptor M3 | ||
Type: | Enzyme | ||
Mol. Mass.: | 66151.03 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P20309 | ||
Residue: | 590 | ||
Sequence: |
| ||
BDBM50296329 | |||
n/a | |||
Name | BDBM50296329 | ||
Synonyms: | (3R)-3-{[Hydroxy(di-2-thienyl)acetyl]oxy}-1-(2-phenylethyl)-1-azoniabicyclo[2.2.2]octane bromide | CHEMBL564057 | US9333195, 36 | US9687478, 36 | ||
Type | Small organic molecule | ||
Emp. Form. | C25H28NO3S2 | ||
Mol. Mass. | 454.624 | ||
SMILES | OC(C(=O)O[C@H]1C[N+]2(CCc3ccccc3)CCC1CC2)(c1cccs1)c1cccs1 |r,wD:5.4,(12.26,-17.08,;11.17,-18.17,;12.51,-18.94,;12.51,-20.48,;13.84,-18.17,;15.17,-18.93,;15.17,-20.47,;16.5,-21.23,;16.49,-22.77,;17.82,-23.56,;19.16,-22.8,;20.48,-23.59,;21.82,-22.83,;21.84,-21.29,;20.5,-20.51,;19.17,-21.27,;17.83,-20.47,;17.83,-18.93,;16.5,-18.15,;16.92,-19.4,;15.87,-19.75,;11.17,-16.63,;9.92,-15.73,;10.39,-14.26,;11.93,-14.26,;12.41,-15.72,;9.84,-18.95,;8.42,-18.32,;7.4,-19.47,;8.17,-20.8,;9.68,-20.48,)| | ||
Structure |